Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China · Delayed Price · Currency is CNY 20.03
-1.05 (-4.98%)
Aug 21, 2026, 3:00 PM CST
SHA:600645 Market Cap
SHA:600645 has a market cap or net worth of 9.13 billion as of August 21, 2026. Its market cap has decreased by -32.47% in one year.
Market Cap
9.13B
Enterprise Value
7.53B
Revenue
1.42B
Ranking
n/a
PE Ratio
83.68
Stock Price
20.03
ChartMarket Cap Chart
Since May 9, 2006, SHA:600645's market cap has increased from 610.06M to 9.13B, an increase of 1,396.83%. That is a compound annual growth rate of 14.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 9.13B | -20.52% |
| Dec 31, 2025 | 11.49B | 30.57% |
| Dec 31, 2024 | 8.80B | -7.24% |
| Dec 29, 2023 | 9.49B | 19.17% |
| Dec 30, 2022 | 7.96B | -32.61% |
| Dec 31, 2021 | 11.81B | 28.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Staidson (Beijing) BioPharmaceuticals | 10.95B |
| Chengzhi | 10.87B |
| Inner Mongolia Furui Medical Science | 10.84B |
| Pacific Shuanglin Bio-pharmacy | 10.49B |
| Hualan Biological Vaccine | 10.41B |
| Chongqing Genrix Biopharmaceutical | 9.49B |
| Jiangxi Fushine Pharmaceutical | 9.46B |
| Beijing Hotgen Biotech | 9.16B |